The present invention provides a phosphorylated SARM1 (Sterile alpha and TIR motif-containing protein 1) in which at least one Ser residue selected from the group consisting of position 54, position 548, and position 622 of SARM1 is phosphorylated.
PHOSPHORYLATED SARM1, ANTIBODY, SARM1 PHOSPHORYLATION INHIBITOR, PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES, SCREENING METHOD, MODIFIED SARM1, AND USE